Plus Therapeutics, Inc. Banner Image

Plus Therapeutics, Inc. has reached its limit for free report views

Work for Plus Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Plus Therapeutics, Inc.

  • Ticker PSTV
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Plus Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Austin, Texas
Plus Therapeutics (Nasdaq: PSTV) is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets. Central to the Company’s drug development is a unique nanotechnology platform designed to reformulate, deliver and commercialize multiple drugs targeting rare cancers and other diseases. The platformMore is designed to facilitate new delivery approaches and/or formulations of safe and effective, injectable drugs, potentially enhancing the safety, efficacy and convenience for patients and healthcare providers.
Plus Therapeutics, Inc.

Most Recent Annual Report

Plus Therapeutics, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Plus Therapeutics, Inc. has reached its limit for free report views.